Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Exchange Rates
Interest Rates
Futures
Economy
Global Metrics

Amicus Therapeutics Shares Outstanding 2007-2018 | FOLD

Amicus Therapeutics shares outstanding from 2007 to 2018. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
Amicus Therapeutics Annual Shares Outstanding
(Millions of Shares)
2018 186
2017 153
2016 134
2015 110
2014 74
2013 51
2012 46
2011 35
2010 28
2009 23
2008 22
2007 13
2006 1
2005 0
Amicus Therapeutics Quarterly Shares Outstanding
(Millions of Shares)
Q4 2018 186
Q3 2018 189
Q2 2018 189
Q1 2018 176
Q4 2017 153
Q3 2017 161
Q2 2017 143
Q1 2017 143
Q4 2016 134
Q3 2016 141
Q2 2016 129
Q1 2016 125
Q4 2015 110
Q3 2015 119
Q2 2015 100
Q1 2015 96
Q4 2014 74
Q3 2014 79
Q2 2014 67
Q1 2014 64
Q4 2013 51
Q3 2013 50
Q2 2013 50
Q1 2013 50
Q4 2012 46
Q3 2012 49
Q2 2012 47
Q1 2012 38
Q4 2011 35
Q3 2011 35
Q2 2011 35
Q1 2011 34
Q4 2010 28
Q3 2010 28
Q2 2010 28
Q1 2010 24
Q4 2009 23
Q3 2009 23
Q2 2009 23
Q1 2009 23
Q4 2008 22
Q3 2008 23
Q2 2008 22
Q1 2008 22
Q4 2007 13
Q3 2007 22
Q2 2007 7
Q1 2007 1
Q3 2006 1
Q2 2006 1
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $2.839B $0.091B
AMICUS THERAPEUTICS is a biopharmaceutical company developing novel, oral therapeutics known as pharmacological chaperones for the treatment of a range of human genetic diseases. Pharmacological chaperone technology involves the use of small molecules that selectively bind to and stabilizeproteins in cells, leading to improved protein folding and trafficking, and increased activity. Amicus is initially targeting lysosomal storage disorders, which are severe, chronic genetic diseases with unmet medical needs. Amicus has completed Phase 2 clinical trials of Amigal(TM) for the treatment of Fabry disease and is conducting Phase 2 clinical trials of Plicera(TM) for the treatment of Gaucher disease.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $109.312B 12.32
Gilead Sciences (GILD) United States $80.293B 10.22
Celgene (CELG) United States $65.862B 12.18
Illumina (ILMN) United States $46.868B 55.77
Biogen (BIIB) United States $44.533B 8.63
Vertex Pharmaceuticals (VRTX) United States $42.991B 57.59
Regeneron Pharmaceuticals (REGN) United States $36.426B 16.92
Alexion Pharmaceuticals (ALXN) United States $28.159B 17.45
Incyte (INCY) United States $15.847B 147.92
BioMarin Pharmaceutical (BMRN) United States $14.833B 0.00
Exact Sciences (EXAS) United States $11.596B 0.00
Seattle Genetics (SGEN) United States $11.135B 0.00
Bio-Rad Laboratories (BIO.B) United States $9.133B 52.39
Alnylam Pharmaceuticals (ALNY) United States $8.724B 0.00
QIAGEN (QGEN) Netherlands $8.637B 28.58
Sarepta Therapeutics (SRPT) United States $8.316B 0.00
Bluebird Bio (BLUE) United States $7.532B 0.00
Moderna (MRNA) United States $7.406B 0.00
BeiGene (BGNE) Cayman Islands $7.154B 0.00
Bio-Techne Corp (TECH) United States $7.144B 48.13
Exelixis (EXEL) United States $6.298B 14.62
Guardant Health (GH) United States $6.059B 0.00
Galapagos (GLPG) Belgium $5.914B 0.00
Amarin (AMRN) Ireland $5.832B 0.00
Alkermes (ALKS) Ireland $5.268B 0.00
Array BioPharma (ARRY) United States $4.886B 0.00
Horizon Pharma Public (HZNP) Ireland $4.596B 13.62
Ascendis Pharma (ASND) Denmark $4.540B 0.00
Spark Therapeutics (ONCE) United States $4.199B 0.00
China Biologic Products (CBPO) China $3.820B 23.67
ARGENX SE-ADR (ARGX) Netherlands $3.806B 0.00
ACADIA Pharmaceuticals (ACAD) United States $3.393B 0.00
Ultragenyx Pharmaceutical (RARE) United States $3.304B 0.00
Blueprint Medicines (BPMC) United States $3.257B 0.00
Immunomedics (IMMU) United States $3.235B 0.00
Allogene Therapeutics (ALLO) United States $3.152B 0.00
Global Blood Therapeutics (GBT) United States $3.089B 0.00
MorphoSys AG Unsponsored ADR (MOR) Germany $3.013B 0.00
Emergent Biosolutions (EBS) United States $2.721B 22.63
Biohaven Pharmaceutical Holding (BHVN) United States $2.664B 0.00
Intercept Pharmaceuticals (ICPT) United States $2.595B 0.00
Ligand Pharmaceuticals (LGND) United States $2.497B 18.64
Akcea Therapeutics (AKCA) United States $2.415B 0.00
Repligen (RGEN) United States $2.405B 74.00
Denali Therapeutics (DNLI) United States $2.398B 0.00
Myriad Genetics (MYGN) United States $2.348B 23.92
Reata Pharmaceuticals (RETA) United States $2.338B 0.00
Halozyme Therapeutics (HALO) United States $2.320B 0.00
Insmed (INSM) United States $2.315B 0.00
Genomic Health (GHDX) United States $2.285B 58.42
Mirati Therapeutics (MRTX) United States $2.231B 0.00
Arena Pharmaceuticals (ARNA) United States $2.179B 0.00
Acceleron Pharma (XLRN) United States $2.091B 0.00
Medicines (MDCO) United States $2.069B 0.00
UniQure (QURE) Netherlands $2.021B 0.00
REGENXBIO (RGNX) United States $2.001B 20.78
AnaptysBio (ANAB) United States $1.997B 0.00
MyoKardia (MYOK) United States $1.910B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.896B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $1.896B 0.00
NeoGenomics (NEO) United States $1.859B 151.23
Zai Lab Unsponsored ADR (ZLAB) China $1.707B 0.00
Audentes Therapeutics (BOLD) United States $1.661B 0.00
Allakos (ALLK) United States $1.623B 0.00
Alector (ALEC) United States $1.548B 0.00
Orchard Therapeutics Sponsored ADR (ORTX) United Kingdom $1.528B 0.00
Atara Biotherapeutics (ATRA) United States $1.471B 0.00
Momenta Pharmaceuticals (MNTA) United States $1.368B 0.00
Rubius Therapeutics (RUBY) United States $1.361B 0.00
Lion Biotechnologies (IOVA) United States $1.338B 0.00
Innoviva (INVA) United States $1.325B 3.65
InflaRx (IFRX) Germany $1.313B 0.00
Myovant Sciences (MYOV) United Kingdom $1.302B 0.00
Cambrex (CBM) United States $1.295B 13.95
Editas Medicine (EDIT) United States $1.267B 0.00
Puma Biotechnology (PBYI) United States $1.266B 0.00
Aimmune Therapeutics (AIMT) United States $1.263B 0.00
Sangamo Therapeutics (SGMO) United States $1.197B 0.00
Apellis Pharmaceuticals (APLS) United States $1.193B 0.00
Epizyme (EPZM) United States $1.150B 0.00
Clovis Oncology (CLVS) United States $1.107B 0.00
Gossamer Bio (GOSS) United States $1.070B 0.00
Codexis (CDXS) United States $1.062B 0.00
Autolus Therapeutics Sponsored ADR (AUTL) United Kingdom $1.059B 0.00
Fate Therapeutics (FATE) United States $1.042B 0.00
Coherus BioSciences (CHRS) United States $1.020B 0.00
NGM BIOPHARMACT (NGM) United States $1.004B 0.00
Genfit SA (GNFT) France $0.945B 0.00
Dicerna Pharmaceuticals (DRNA) United States $0.941B 0.00
Rhythm Pharmaceuticals (RYTM) United States $0.903B 0.00
Deciphera Pharmaceuticals (DCPH) United States $0.896B 0.00
Kiniksa Pharmaceuticals (KNSA) Bermuda $0.894B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.890B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.877B 35.43
WAVE Life Sciences (WVE) Singapore $0.875B 0.00
Alder BioPharmaceuticals (ALDR) United States $0.869B 0.00
RA PHARMCTL INC (RARX) United States $0.868B 0.00
Eidos Therapeutics (EIDX) United States $0.868B 0.00
Twist Bioscience (TWST) United States $0.836B 0.00
Cellectis (CLLS) France $0.836B 0.00
Retrophin (RTRX) United States $0.831B 0.00
ANI Pharmaceuticals (ANIP) United States $0.816B 14.94
Athenex (ATNX) United States $0.741B 0.00
Arvinas (ARVN) United States $0.738B 0.00
Intellia Therapeutics (NTLA) United States $0.734B 0.00
Inotek Pharmaceuticals (RCKT) United States $0.733B 0.00
Vericel (VCEL) United States $0.729B 0.00
Cara Therapeutics (CARA) United States $0.717B 0.00
Nightstar Therapeutics Sponsored ADR (NITE) United Kingdom $0.717B 0.00
Principia Biopharma (PRNB) United States $0.707B 0.00
Intra-Cellular Therapies (ITCI) United States $0.676B 0.00
G1 THERAPEUTICS (GTHX) United States $0.662B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.661B 0.00
Viking Therapeutics (VKTX) United States $0.635B 0.00
MeiraGTx Holdings (MGTX) United States $0.614B 0.00
ObsEva SA (OBSV) Switzerland $0.608B 0.00
Precision BioSciences (DTIL) United States $0.597B 0.00
Revance Therapeutics (RVNC) United States $0.594B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.593B 0.00
Heska (HSKA) United States $0.576B 51.69
Kura Oncology (KURA) United States $0.569B 0.00
Zealand Pharma (ZEAL) Denmark $0.563B 6.26
Stemline Therapeutics (STML) United States $0.562B 0.00
Synthorx (THOR) United States $0.544B 0.00
Acorda Therapeutics (ACOR) United States $0.531B 6.88
DBV Technologies (DBVT) France $0.521B 0.00
Mesoblast (MESO) Australia $0.520B 0.00
Zymeworks (ZYME) Canada $0.514B 0.00
UROGEN PHARMA (URGN) United States $0.503B 0.00
Magenta Therapeutics (MGTA) United States $0.502B 0.00
Arcus Biosciences (RCUS) United States $0.500B 0.00
Axsome Therapeutics (AXSM) United States $0.500B 0.00
AVROBIO (AVRO) United States $0.486B 0.00
Sorrento Therapeutics (SRNE) United States $0.470B 0.00
Replimune (REPL) United States $0.459B 0.00
PDL BioPharma (PDLI) United States $0.459B 10.23
Scholar Rock Holding (SRRK) United States $0.457B 0.00
Krystal Biotech (KRYS) United States $0.453B 0.00
CytomX Therapeutics (CTMX) United States $0.451B 0.00
Anika Therapeutics (ANIK) United States $0.450B 17.01
Cytokineticsorporated (CYTK) United States $0.447B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.441B 0.00
KALEIDO BIOSCI (KLDO) $0.438B 0.00
NuCana Sponsored ADR (NCNA) United Kingdom $0.437B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.431B 0.00
Five Prime Therapeutics (FPRX) United States $0.430B 0.00
Prothena (PRTA) Ireland $0.427B 0.00
CYCLERION THERA (CYCN) United States $0.425B 0.00
Dynavax Technologies (DVAX) United States $0.410B 0.00
Achillion Pharmaceuticals (ACHN) United States $0.406B 0.00
Senesco Technologies (ELOX) United States $0.404B 0.00
Gritstone Oncology (GRTS) United States $0.401B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.399B 0.00
MediciNova (MNOV) United States $0.389B 0.00
Abeona Therapeutics (ABEO) United States $0.383B 0.00
Adverum Biotechnologies (ADVM) United States $0.378B 0.00
Albireo Pharma (ALBO) United States $0.373B 0.00
Sinovac Biotech (SVA) China $0.371B 0.00
Kezar Life Sciences (KZR) United States $0.368B 0.00
Inovio Pharmaceuticals (INO) United States $0.364B 0.00
Merus (MRUS) Netherlands $0.357B 0.00
STEALTH BIOTHER (MITO) United States $0.355B 0.00
BeyondSpring (BYSI) United States $0.347B 0.00
UNITY Biotechnology (UBX) $0.343B 0.00
Kindred Biosciences (KIN) United States $0.340B 0.00
Agenus (AGEN) United States $0.340B 0.00
Geron (GERN) United States $0.330B 0.00
BioDelivery Sciences (BDSI) United States $0.330B 0.00
Solid Biosciences (SLDB) United States $0.326B 0.00
AC Immune SA (ACIU) Switzerland $0.319B 0.00
Biofrontera AG Sponsored ADR (BFRA) Germany $0.315B 0.00
PHASEBIO PHARMA (PHAS) United States $0.314B 0.00
XBiotech (XBIT) United States $0.314B 0.00
Cellular Biomedicine (CBMG) United States $0.312B 0.00
Constellation Pharmaceuticals (CNST) United States $0.307B 0.00
Kadmon Holdings (KDMN) United States $0.292B 0.00
MannKind (MNKD) United States $0.287B 0.00
Seres Therapeutics (MCRB) United States $0.283B 0.00
LogicBio Therapeutics (LOGC) United States $0.272B 0.00
Kodiak Sciences (KOD) United States $0.271B 0.00
Aduro Biotech (ADRO) United States $0.270B 0.00
Evelo Biosciences (EVLO) United States $0.265B 0.00
Enochian BioSciences (ENOB) United States $0.260B 0.00
Kala Pharmaceuticals (KALA) United States $0.258B 0.00
Kamada (KMDA) Israel $0.248B 11.22
Novavax (NVAX) United States $0.245B 0.00
Protagonist Therapeutics (PTGX) United States $0.244B 0.00
Strongbridge Biopharma (SBBP) United States $0.244B 0.00
Urovant Sciences (UROV) United States $0.244B 0.00
Avid Bioservices (CDMO) United States $0.243B 0.00
Sutro Biopharma (STRO) United States $0.238B 0.00
ResTORbio (TORC) United States $0.237B 0.00
Syros Pharmaceuticals (SYRS) United States $0.231B 0.00
ChromaDex (CDXC) United States $0.228B 0.00
Cerecor (CERC) United States $0.227B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.219B 0.00
ADMA Biologics Inc (ADMA) United States $0.214B 0.00
Celcuity (CELC) United States $0.213B 0.00
Eiger BioPharmaceuticals (EIGR) United States $0.212B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.212B 0.00
OvaScience (MLND) United States $0.211B 0.00
OSMOTICA PHARM (OSMT) United States $0.210B 0.00
Intec Pharma (NTEC) Israel $0.210B 0.00
Gamida Cell (GMDA) Israel $0.207B 0.00
Synlogic (SYBX) United States $0.204B 0.00
Athersys (ATHX) United States $0.204B 0.00
Spero Therapeutics (SPRO) United States $0.204B 0.00
Axovant Sciences (AXGT) United Kingdom $0.200B 0.00
Celyad SA (CYAD) Belgium $0.199B 0.00
Mersana Therapeutics (MRSN) United States $0.198B 0.00
TOCAGEN INC (TOCA) United States $0.195B 0.00
VBI Vaccines (VBIV) United States $0.192B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.181B 0.00
Arbutus Biopharma (ABUS) Canada $0.178B 0.00
Arsanis (XFOR) United States $0.178B 0.00
Cue Biopharma (CUE) United States $0.177B 0.00
Compugen (CGEN) Israel $0.174B 0.00
Menlo Therapeutics (MNLO) United States $0.170B 0.00
Enzo Biochem (ENZ) United States $0.169B 0.00
Verastem (VSTM) United States $0.160B 0.00
Mustang Bio (MBIO) United States $0.160B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.157B 0.00
BioXcel Therapeutics (BTAI) United States $0.152B 0.00
Chiasma (CHMA) United States $0.145B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.142B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.141B 0.00
Liquidia Technologies (LQDA) United States $0.141B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.140B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.139B 0.00
Trevena (TRVN) United States $0.139B 0.00
Anavex Life Sciences (AVXL) United States $0.137B 0.00
Erytech Pharma SA Sponsored ADR (ERYP) France $0.136B 0.00
Eton Pharmaceuticals (ETON) United States $0.132B 0.00
Allena Pharmaceuticals (ALNA) United States $0.132B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.128B 0.00
Aptinyx (APTX) United States $0.125B 0.00
Organovo Holdings (ONVO) United States $0.121B 0.00
Checkpoint Therapeutics (CKPT) United States $0.119B 0.00
Provention Bio (PRVB) United States $0.118B 0.00
Spring Bank Pharmaceuticals (SBPH) United States $0.117B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.116B 0.00
Neothetics (EVFM) United States $0.115B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.112B 0.00
Unum Therapeutics (UMRX) United States $0.108B 0.00
XOMA (XOMA) United States $0.107B 0.00
Catalyst Biosciences (CBIO) United States $0.104B 0.00
Selecta Biosciences (SELB) United States $0.103B 0.00
Cohbar (CWBR) United States $0.102B 0.00
INMUNE BIO INC (INMB) United States $0.098B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.093B 0.00
Equillium (EQ) United States $0.093B 0.00
Fortress Biotech (FBIO) United States $0.092B 0.00
NantKwest (NK) United States $0.092B 0.00
SESEN BIO, INC (SESN) United States $0.091B 0.00
Signal Genetics (MGEN) United States $0.084B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $0.084B 0.00
Applied Genetic Technologies (AGTC) United States $0.083B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.082B 0.00
Alcobra (ARCT) United States $0.081B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.080B 0.00
Cocrystal Pharma (COCP) United States $0.079B 83.67
Eyenovia (EYEN) United States $0.078B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.078B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.078B 0.00
Tiziana Life Sciences Sponsored ADR (TLSA) United Kingdom $0.077B 0.00
Orgenesis (ORGS) United States $0.074B 0.00
Aptose Biosciences (APTO) Canada $0.074B 0.00
ARAVIVE, INC (ARAV) United States $0.070B 0.00
AEterna Zentaris (AEZS) United States $0.070B 17.00
OVID THERAPEUTC (OVID) United States $0.068B 0.00
Cidara Therapeutics (CDTX) United States $0.066B 0.00
Idera Pharmaceuticals (IDRA) United States $0.066B 0.00
Alimera Sciences (ALIM) United States $0.065B 0.00
Proteostasis Therapeutics (PTI) United States $0.061B 0.00
Sienna Biopharmaceuticals (SNNA) United States $0.061B 0.00
VTv Therapeutics (VTVT) United States $0.060B 0.00
NewLink Genetics (NLNK) United States $0.059B 0.00
Apricus Biosciences (SEEL) United States $0.059B 0.00
Vaccinex (VCNX) United States $0.059B 0.00
Curis (CRIS) United States $0.059B 0.00
Pluristem Therapeutics (PSTI) Israel $0.059B 0.00
Evogene (EVGN) Israel $0.058B 0.00
Ophthotech (ISEE) United States $0.058B 0.00
Zosano Pharma (ZSAN) United States $0.058B 0.00
ScPharmaceuticals (SCPH) United States $0.057B 0.00
Prima BioMed (IMMP) Australia $0.052B 0.00
Vascular Biogenics (VBLT) Israel $0.051B 0.00
AquaBounty Technologies (AQB) United States $0.049B 0.00
HOTH THERAPEUTC (HOTH) United States $0.048B 0.00
Entera Bio (ENTX) Israel $0.048B 0.00
VistaGen Therapeutics (VTGN) United States $0.048B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.048B 0.00
DiaMedica Therapeutics (DMAC) United States $0.047B 0.00
Celldex Therapeutics (CLDX) United States $0.047B 0.00
INNOVATE BIOPHARMACEUTICALS, INC (INNT) United States $0.046B 0.00
AZURRX BIOPHARM (AZRX) United States $0.046B 0.00
Celsion (CLSN) United States $0.046B 0.00
ANCHIANO THERAP (ANCN) Israel $0.045B 0.00
Bellerophon Therapeutics (BLPH) United States $0.045B 0.00
Clearside Biomedical (CLSD) United States $0.045B 0.00
BiondVax Pharmaceuticals (BVXV) Israel $0.044B 0.00
Bionano Genomics (BNGO) United States $0.044B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.040B 0.00
VIVUS (VVUS) United States $0.039B 0.00
Moleculin Biotech (MBRX) United States $0.038B 0.00
OncoSec Medical (ONCS) United States $0.037B 0.00
OncoMed Pharmaceuticals (OMED) United States $0.036B 0.00
Aptevo Therapeutics (APVO) United States $0.035B 0.00
Leap Therapeutics (LPTX) United States $0.034B 0.00
Oncolytics Biotech (ONCY) Canada $0.034B 0.00
Motif Bio Plc (MTFB) United States $0.031B 0.00
Caladrius Biosciences (CLBS) United States $0.031B 0.00
Sophiris Bio (SPHS) United States $0.030B 0.00
GTx (GTXI) United States $0.027B 0.00
GENPREX INC (GNPX) United States $0.027B 0.00
Adial Pharmaceuticals (ADIL) United States $0.027B 0.00
Novelion Therapeutics (NVLN) Canada $0.025B 0.00
Aileron Therapeutics (ALRN) United States $0.025B 0.00
Vical (VICL) United States $0.025B 0.00
Titan Pharmaceuticals (TTNP) United States $0.023B 0.00
Aytu Bioscience (AYTU) United States $0.023B 0.00
Galena Biopharma (SLS) United States $0.022B 0.00
Fibrocell Science Inc (FCSC) United States $0.022B 0.00
TRACON Pharmaceuticals (TCON) United States $0.021B 0.00
IMMURON LTD (IMRN) Australia $0.021B 0.00
ATyr Pharma (LIFE) United States $0.020B 0.00
Benitec Biopharma (BNTC) Australia $0.019B 0.00
CytRx (CYTR) United States $0.019B 0.00
Oncobiologics (OTLK) United States $0.019B 0.00
Histogenics (HSGX) United States $0.018B 0.00
Advaxis (ADXS) United States $0.018B 0.00
Gemphire Therapeutics (GEMP) United States $0.018B 0.00
Vital Therapies (IMUX) United States $0.017B 0.00
Cleveland BioLabs (CBLI) United States $0.017B 0.00
Prana Biotechnology (ATHE) Australia $0.016B 0.00
Novogen (KZIA) Australia $0.016B 0.00
Alliqua BioMedical (ALQA) United States $0.014B 0.00
TrovaGene (TROV) United States $0.014B 0.00
Soligenix (SNGX) United States $0.013B 0.00
Genetic Technologies (GENE) Australia $0.013B 0.00
MYOS RENS Technology (MYOS) United States $0.013B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.012B 0.00
Therapix Biosciences (TRPX) Israel $0.012B 5.96
Dare Bioscience (DARE) United States $0.012B 0.00
RestorGenex (DFFN) United States $0.011B 0.00
Tenax Therapeutics (TENX) United States $0.010B 0.00
Proteon Therapeutics (PRTO) United States $0.010B 0.00
Flex Pharma (FLKS) United States $0.010B 0.00
Edge Therapeutics (PDSB) United States $0.009B 0.00
Neuralstem (CUR) United States $0.008B 0.00
Pulmatrix (PULM) United States $0.008B 0.00
ARCA Biopharma (ABIO) United States $0.006B 0.00
Stellar Biotechnologies (SBOT) United States $0.005B 0.00
Cytori Therapeutics Inc (CYTX) United States $0.005B 0.00
Cellect Biotechnology (APOP) Israel $0.005B 0.00
ContraVir Pharmaceuticals Inc (CTRV) United States $0.005B 0.00